517 related articles for article (PubMed ID: 8035314)
21. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.
Kazmi SM; Mishra RK
Mol Pharmacol; 1987 Jul; 32(1):109-18. PubMed ID: 3037297
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of mu- and delta-receptor selective opioid agonists on feedforward and feedback GABAergic inhibition in hippocampal brain slices.
Lupica CR; Dunwiddie TV
Synapse; 1991 Aug; 8(4):237-48. PubMed ID: 1656539
[TBL] [Abstract][Full Text] [Related]
23. Agonist Activity of the delta-antagonists TIPP and TIPP-psi in cellular models expressing endogenous or transfected delta-opioid receptors.
Martin NA; Terruso MT; Prather PL
J Pharmacol Exp Ther; 2001 Jul; 298(1):240-8. PubMed ID: 11408548
[TBL] [Abstract][Full Text] [Related]
24. Localization of Mu and delta opioid receptors to anterior cingulate afferents and projection neurons and input/output model of Mu regulation.
Vogt BA; Wiley RG; Jensen EL
Exp Neurol; 1995 Oct; 135(2):83-92. PubMed ID: 7589327
[TBL] [Abstract][Full Text] [Related]
25. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
[TBL] [Abstract][Full Text] [Related]
26. Reversible modulation of opioid receptor binding in intact neural cells by endogenous guanosine triphosphate.
Yabaluri N; Medzihradsky F
Mol Pharmacol; 1995 Oct; 48(4):690-5. PubMed ID: 7476895
[TBL] [Abstract][Full Text] [Related]
27. Differences among mouse strains in the regulation by mu, delta 1 and delta 2 opioid receptors of striatal adenylyl cyclases activated by dopamine D1 or adenosine A2a receptors.
Noble F; Cox BM
Brain Res; 1996 Apr; 716(1-2):107-17. PubMed ID: 8738226
[TBL] [Abstract][Full Text] [Related]
28. Effect of forskolin and isobutylmethylxanthine on delta-opioid receptor activity in neuroblastoma x glioma NG108-15 cells.
Bergsbaken CL; Sommers SL; Law PY
J Pharmacol Exp Ther; 1993 Mar; 264(3):1474-83. PubMed ID: 7680718
[TBL] [Abstract][Full Text] [Related]
29. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
Schoffelmeer AN; De Vries TJ; Hogenboom F; Mulder AH
J Pharmacol Exp Ther; 1993 Oct; 267(1):205-10. PubMed ID: 8229747
[TBL] [Abstract][Full Text] [Related]
30. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
[TBL] [Abstract][Full Text] [Related]
31. Identification of mechanisms and sites of actions of mu and delta opioid receptor activation in the canine intestine.
Fox-Threlkeld JE; Daniel EE; Christinck F; Hruby VJ; Cipris S; Woskowska Z
J Pharmacol Exp Ther; 1994 Feb; 268(2):689-700. PubMed ID: 8113980
[TBL] [Abstract][Full Text] [Related]
32. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
Stewart PE; Hammond DL
J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
[TBL] [Abstract][Full Text] [Related]
33. Differential coupling of mu-, delta-, and kappa-opioid receptors to G alpha16-mediated stimulation of phospholipase C.
Lee JW; Joshi S; Chan JS; Wong YH
J Neurochem; 1998 May; 70(5):2203-11. PubMed ID: 9572309
[TBL] [Abstract][Full Text] [Related]
34. Modulation of protein kinase C and cAMP-dependent protein kinase by delta-opioid.
Lou LG; Pei G
Biochem Biophys Res Commun; 1997 Jul; 236(3):626-9. PubMed ID: 9245701
[TBL] [Abstract][Full Text] [Related]
35. Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells.
Carter BD; Medzihradsky F
Mol Pharmacol; 1993 Mar; 43(3):465-73. PubMed ID: 8383804
[TBL] [Abstract][Full Text] [Related]
36. Interaction between highly selective mu and delta opioids in vivo at the rat spinal cord.
Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
NIDA Res Monogr; 1986; 75():97-100. PubMed ID: 2829017
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of impaired mitochondrial energy production on the function of mu and delta opioid receptors in neuronal SK-N-SH cells.
Raut A; Iglewski M; Ratka A
Neurosci Lett; 2006 Aug; 404(1-2):242-6. PubMed ID: 16808998
[TBL] [Abstract][Full Text] [Related]
38. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
[TBL] [Abstract][Full Text] [Related]
39. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
[TBL] [Abstract][Full Text] [Related]
40. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
